Cooley LLP advised CStone Pharmaceuticals on the deal. Biopharmaceutical company CStone Pharmaceuticals, whose securities trade on the Hong Kong Stock Exchange, announced its $200 million investment…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
